Sky Medical Technology Honoured at the Medilink Awards - Seite 2

The investigators, led by Dr. Indira Natarajan, Consultant Stroke Physician and Clinical Director for Neurosciences and Professor Christine Roffe, qualified that 30% of their acute Stroke patients are contraindicated or became intolerant to SCDs (sequential compression devices). It is to this unmet need cohort they fitted the geko device, reporting a zero VTE incidence at 90 days and good patient tolerance. Their findings have accelerated geko device adoption across multiple NHS trusts and international markets, as well as expanded FDA clearances for the prevention of VTE.  

Sky will now go forward to the Medilink UK Healthcare Business Awards, with the hope to be crowned national winner at the prestigious awards ceremony on the 1^st of April 2020, at the Hilton Birmingham Metropole, located in the NEC. Hosted annually, in association with Med-Tech Innovation (MTI), the Medilink awards celebrate the outstanding business achievements, international successes and innovative breakthroughs made across the Life Sciences and Healthcare Technology sectors in the past year.

At the Med-Tech Innovation EXPO, which hosts the Medilink Awards ceremony, Sky will present how the geko device was conceived and the R&D processes and challenges in bringing innovation to market, on the HealthTech stage, D80, at 1.00pm – 1.30pm, as part of the conference track dedicated to wearables. https://med-techexpo.com/event/en/node/biringing-to-market:-the-geko-device.

MTI EXPO is a showcase for medical design and manufacturing technology, taking place 1-2 April 2020 at the NEC, Birmingham Med-Tech Innovation Expo.

About the geko device

Through its innovative mechanism of bioelectronic neuromuscular electrostimulation, the geko device gently stimulates the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf. The size of a wrist-watch and worn at the knee, the easy-to-use geko device operates without external pressure to the leg and allows complete patient mobility.

About Sky Medical Technology Ltd and Firstkind Ltd.

Sky Medical Technology Ltd, is a UK-based medical devices company and parent company of Firstkind Ltd, the marketing arm of Sky.  Through its innovative mechanism of non-invasive neuromuscular electrostimulation, the Company has developed a ground-breaking bioelectronic technology platform, OnPulse, embedded in its industry-leading brand, the geko device. The company develops a range of wearable therapy devices tailored to the needs of different medical application areas, selling through strategic partnerships and distributors in each application area. Clinical areas of interest include DVT prevention, oedema management and wound healing. The goal in each pathway is to partner with healthcare professionals to improve clinical outcomes and patient care whilst saving health system resources.